Maternal phenylketonuria: report from the United Kingdom Registry 1978-97

P J Lee1, D Ridout, J H Walter

  • 1The Charles Dent Metabolic Unit, The National Hospital for Neurology & Neurosurgery, London, UK. philip.lee@uclh.org

Insights

Starting a phenylalanine-restricted diet before conception significantly improves outcomes for pregnant women with phenylketonuria (PKU). Early dietary intervention in PKU pregnancies prevents developmental issues and congenital heart disease in offspring.

Area of Science:

  • Maternal-fetal medicine
  • Metabolic disorders
  • Genetics

Background:

  • Maternal phenylketonuria (PKU) poses significant risks to fetal development, including facial dysmorphism, microcephaly, intrauterine growth retardation, developmental delays, and congenital heart disease (CHD).
  • Effective management of maternal PKU is crucial for preventing adverse pregnancy outcomes.

Purpose of the Study:

  • To evaluate the impact of a phenylalanine-restricted diet in pregnant women with PKU on offspring development and health.
  • To determine the optimal timing for initiating dietary intervention during pregnancy.

Main Methods:

  • A retrospective analysis of pregnancies in women with PKU in the United Kingdom (1978-1997) using data from the UK PKU Registry.
  • Examined the effects of pre-conception versus in-pregnancy initiation of a phenylalanine-restricted diet on birth weight, head circumference, incidence of CHD, and developmental/intelligence quotients at 4 and 8 years.

Main Results:

  • Pregnancies with pre-conception dietary intervention (n=110) showed significantly better outcomes: higher birth weight (3160g vs 2818g), larger head circumference (33.6cm vs 32.7cm), higher 4-year DQ (108.9 vs 96.8), higher 8-year IQ (103.4 vs 86.5), and lower CHD incidence (2.4% vs 17%) compared to those treated during pregnancy (n=91).
  • Metabolic control achieved by 12-16 weeks of gestation was identified as critical for influencing pregnancy outcomes.

Conclusions:

  • The adverse effects associated with maternal PKU syndrome are largely preventable with a phenylalanine-restricted diet.
  • Early initiation of a phenylalanine-restricted diet, ideally before conception or as early as possible in pregnancy, is essential for women with PKU and their healthcare providers to be aware of these risks and recommendations.
Abstract

Related Concept Videos

Pedigree Analysis01:35

Pedigree Analysis

Overview
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...